BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Here's your Monthly Dose my supplement spotlight on what's trending, what's promising, and what actually holds up under scientific scrutiny. This month: BPC 157. Often called the injury recovery peptide, BPC 157 has In this video, I discuss the dosage recommendations for BPC 157. Although there are no human clinical trials on optimal dosing, we rely on animal literature and anecdotal evidence. For oral BPC 157: Tendon Repair and More The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics